<html>
<head>
<title>Utah Legislature HB0152</title>
</head>
<body>
<div id="content">
<font face="Arial">
</font><font face="Arial" size="3">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>INFERTILITY INSURANCE COVERAGE AMENDMENTS</b></font><font face="Arial" size="2"></center><br/>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>2015 GENERAL SESSION</center><br/>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>STATE OF UTAH</center><br/>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3"><b>Chief Sponsor:  LaVar Christensen</b></font><font face="Arial" size="2"></center><br/>5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3">Senate Sponsor: </font><font face="Arial" size="2"></font><font face="Arial" size="3">  Brian E. Shiozawa</font><font face="Arial" size="2"></center><br/>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>LONG TITLE</b><br/>8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>General Description:</b><br/>9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill amends the Insurance Code related to accident and health insurance.<br/>10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Highlighted Provisions:</b><br/>11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill:<br/>12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amends the price and value comparison disclosure requirements for an insurer to<br/>13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;require an insurer to disclose to an enrollee information about infertility coverage.<br/>14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Money Appropriated in this Bill:</b><br/>15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Other Special Clauses:</b><br/>17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill provides a special effective date.<br/>18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Utah Code Sections Affected:</b><br/>19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;AMENDS:<br/>20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#31a-22-613.5">31A-22-613.5</a></b>, as last amended by Laws of Utah 2012, Chapter 279<br/>21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Be it enacted by the Legislature of the state of Utah:</i><br/>23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.  Section <b>31A-22-613.5</b><a name="31a-22-613.5"></a> is amended to read:<br/>24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>31A-22-613.5.</b>   <b>Price and value comparisons of health insurance.</b><br/>25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) (a)  This section applies to all health benefit plans.<br/>26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  Subsection (2) applies to:<br/>27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  all health benefit plans; and<br/><hr>28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  coverage offered to state employees under Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=49-20-202&session=2015GS">49-20-202</a>(1)(a).<br/>29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) (a)  The commissioner shall promote informed consumer behavior and responsible<br/>30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;health benefit plans by requiring an insurer issuing a health benefit plan to:<br/>31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  provide to all enrollees, prior to enrollment in the health benefit plan written<br/>32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;disclosure of:<br/>33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  restrictions or limitations on prescription drugs and biologics including:<br/>34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(I)  the use of a formulary;<br/>35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(II)  co-payments and deductibles for prescription drugs; and<br/>36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(III)  requirements for generic substitution;<br/>37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  coverage limits under the plan; [<strike>and</strike>]<br/>38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)  any limitation or exclusion of coverage including:<br/>39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(I)  a limitation or exclusion for a secondary medical condition related to a limitation or<br/>40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;exclusion from coverage; and<br/>41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(II)  easily understood examples of a limitation or exclusion of coverage for a secondary<br/>42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;medical condition; and<br/>43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(D)  whether the insurer permits an exchange of the adoption indemnity benefit in</u><br/>44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=31a-22-610.1&session=2015GS">31A-22-610.1</a> for infertility treatments, in accordance with Subsection</u><br/>45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u><a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=31a-22-610.1&session=2015GS">31A-22-610.1</a>(1)(c)(ii) and the terms associated with the exchange of benefits; and</u><br/>46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  provide the commissioner with:<br/>47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  the information described in Subsections <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=31a-22-635&session=2015GS">31A-22-635</a>(5) through (7) in the<br/>48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;standardized electronic format required by Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=63m-1-2506&session=2015GS">63M-1-2506</a>(1); and<br/>49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  information regarding insurer transparency in accordance with Subsection (4).<br/>50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  An insurer shall provide the disclosure required by Subsection (2)(a)(i) in writing to<br/>51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the commissioner:<br/>52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  upon commencement of operations in the state; and<br/>53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  anytime the insurer amends any of the following described in Subsection (2)(a)(i):<br/>54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  treatment policies;<br/>55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  practice standards;<br/>56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(C)  restrictions;<br/>57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(D)  coverage limits of the insurer's health benefit plan or health insurance policy; or<br/>58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(E)  limitations or exclusions of coverage including a limitation or exclusion for a<br/><hr>59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;secondary medical condition related to a limitation or exclusion of the insurer's health<br/>60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;insurance plan.<br/>61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  An insurer shall provide the enrollee with notice of an increase in costs for<br/>62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;prescription drug coverage due to a change in benefit design under Subsection (2)(a)(i)(A):<br/>63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  either:<br/>64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)  in writing; or<br/>65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)  on the insurer's website; and<br/>66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  at least 30 days prior to the date of the implementation of the increase in cost, or as<br/>67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;soon as reasonably possible.<br/>68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)  If under Subsection (2)(a)(i)(A) a formulary is used, the insurer shall make<br/>69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;available to prospective enrollees and maintain evidence of the fact of the disclosure of:<br/>70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the drugs included;<br/>71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the patented drugs not included;<br/>72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  any conditions that exist as a precedent to coverage; and<br/>73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)  any exclusion from coverage for secondary medical conditions that may result<br/>74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;from the use of an excluded drug.<br/>75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) (i)  The commissioner shall develop examples of limitations or exclusions of a<br/>76&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;secondary medical condition that an insurer may use under Subsection (2)(a)(i)(C).<br/>77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  Examples of a limitation or exclusion of coverage provided under Subsection<br/>78&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)(a)(i)(C) or otherwise are for illustrative purposes only, and the failure of a particular fact<br/>79&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;situation to fall within the description of an example does not, by itself, support a finding of<br/>80&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;coverage.<br/>81&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)  The commissioner:<br/>82&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  shall forward the information submitted by an insurer under Subsection (2)(a)(ii) to<br/>83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the Health Insurance Exchange created under Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=63m-1-2504&session=2015GS">63M-1-2504</a>; and<br/>84&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  may request information from an insurer to verify the information submitted by the<br/>85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;insurer under this section.<br/>86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(4)  The commissioner shall:<br/>87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)  convene a group of insurers, a member representing the Public Employees' Benefit<br/>88&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and Insurance Program, consumers, and an organization that provides multipayer and<br/>89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;multiprovider quality assurance and data collection, to develop information for consumers to<br/><hr>90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;compare health insurers and health benefit plans on the Health Insurance Exchange, which<br/>91&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shall include consideration of:<br/>92&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  the number and cost of an insurer's denied health claims;<br/>93&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the cost of denied claims that is transferred to providers;<br/>94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  the average out-of-pocket expenses incurred by participants in each health benefit<br/>95&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;plan that is offered by an insurer in the Health Insurance Exchange;<br/>96&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)  the relative efficiency and quality of claims administration and other administrative<br/>97&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;processes for each insurer offering plans in the Health Insurance Exchange; and<br/>98&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)  consumer assessment of each insurer or health benefit plan;<br/>99&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)  adopt an administrative rule that establishes:<br/>100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)  definition of terms;<br/>101&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)  the methodology for determining and comparing the insurer transparency<br/>102&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;information;<br/>103&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)  the data, and format of the data, that an insurer shall submit to the commissioner in<br/>104&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;order to facilitate the consumer comparison on the Health Insurance Exchange in accordance<br/>105&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=63m-1-2506&session=2015GS">63M-1-2506</a>; and<br/>106&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)  the dates on which the insurer shall submit the data to the commissioner in order<br/>107&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for the commissioner to transmit the data to the Health Insurance Exchange in accordance with<br/>108&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=63m-1-2506&session=2015GS">63M-1-2506</a>; and<br/>109&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)  implement the rules adopted under Subsection (4)(b) in a manner that protects the<br/>110&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;business confidentiality of the insurer.<br/>111&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.  <b>Effective date.</b><br/>112&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>This bill takes effect on July 1, 2015.</u><br/><br/><hr style="width:90%; color: #333; text-align: right" /><br/><hr style="width:90%; color: #333; text-align: right" /><br/><br/><b>Legislative Review Note<br/>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;as of   1-16-15  9:58 AM</b><br/><br/><div align="right"><b>Office of Legislative Research and General Counsel</b></div>
</font>
</div>
</body>
</html>
